XM does not provide services to residents of the United States of America.

UK's Pets At Home looks to bolster accessory sales



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 2-UK's Pets At Home looks to bolster accessory sales</title></head><body>

Aims to increase accessory sales this year

Reiterates 9% profit growth target

Shares up 2.3% in morning trade

Recasts, adds shares in paragraph 3, analyst in paragraph 8

By Echha Jain and Radhika Anilkumar

May 29 (Reuters) -Britain's Pets At Home PETSP.L aims to bolster sales of pet accessories this year, it said on Wednesday, and added it expects no impact on its growth plans from a UK probe of the veterinarian services sector launched last week.

The UK's second biggest vet care provider also reported a 3.2% fall in underlying profit before tax for the year ended on March 28 to 132 million pounds ($168 million), in line with analyst forecasts.

Its shares were up 2.3% in morning trade.

Pet owners have curbed spending on luxury items like expensive toys, hurting Pets At Home's performance, something the company said it aimed to address.

"We plan to return accessories to growth through driving premiumisation, leveraging exclusive licences and tie-ups, and creating points of engagement around major events," it said in a statement.

It also announced a 25 million pound buyback programme for this fiscal year.

The pet supplies retailer, which also offers grooming and veterinary services, flagged subdued trading in the first six weeks of the current fiscal year but reiterated it expect 9% profit growth.

"Pets At Home remains in a more resilient position than the average retailer," Sophie Lund-Yates, lead equity analyst at Hargreaves Lansdown, wrote in a client note.

The company said its growth strategy was not threatened by a probe into the vets sector launched by the Competition and Markets Authority last week.

Its shares have fallen about 25% since the competition regulator started a review of the vet industry last September.

($1 = 0.7837 pounds)



Reporting by Echha Jain in Bengaluru; editing by Savio D'Souza, Subhranshu Sahu and Jason Neely

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.